• 11:00am - 11:10am

  Opening Remarks
  Robert J. Mayer MD – Course Director

Women’s Cancers

Track Leader: Dr. Burstein

• 11:10am - 11:50am

  Molecular Advances and Emerging Treatment Strategies in Ovarian and Endometrial Cancers
  Ursula A. Matulonis MD

  Download Molecular Advances and Emerging Treatment Strategies in Ovarian and Endometrial Cancers

• 11:50am - 12:30pm

  HER2-Positive and Triple-Negative Breast Cancers: An Evolving Treatment Landscape
  Eric P. Winer MD

  Download HER2-Positive and Triple-Negative Breast Cancers: An Evolving Treatment Landscape

• 12:30pm - 1:10pm

  Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes
  Harold J. Burstein MD, PhD

  Download Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

• 1:10pm - 1:40pm

  Session Break
  

Supportive Care

Moderator: Dr. Burstein

• 1:40pm - 2:10pm

  Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes
  Janet L. Abrahm MD

  Download Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

• 2:10pm - 2:40pm

  Optimizing Outcomes for Survivors of Cancer
  Ann H. Partridge MD, MPH

  Download Optimizing Outcomes for Survivors of Cancer

• 2:40pm - 3:10pm

  Panel Discussion
  

  All Faculty

• 3:10pm - 3:15pm

  Closing Remarks
  

• 11:00am - 11:10am

  Opening Remarks
  Robert J. Mayer MD – Course Director

Hematologic Malignancies

Moderator: Dr. Connors

• 11:10am - 11:55am

  Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach
  Ann S. LaCasce MD, MMSC

  Download Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

• 11:55am - 12:40pm

  Myeloid Malignancies: Molecular Markers and Targeted Therapies
  Richard M. Stone MD

  Download Myeloid Malignancies: Molecular Markers and Targeted Therapies

• 12:40pm - 1:05pm

  Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management
  Ayalew Tefferi MD

  Download Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

• 1:05pm - 1:30pm

  Multiple Myeloma: Current Evidence-Based Management
  Kenneth C. Anderson MD

  Download Multiple Myeloma: Current Evidence-Based Management

• 1:30pm - 2:00pm

  Session Break
  

• 2:00pm - 2:25pm

  Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape
  John C. Byrd MD

  Download Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

• 2:25pm - 2:50pm

  Cancer Associated Venous Thromboembolic Disease: Current Guidance and Clinical Data
  Jean M. Connors MD

  Download Cancer Associated Venous Thromboembolic Disease: Current Guidance and Clinical Data

• 2:50pm - 3:20pm

  Panel Discussion
  

  All Faculty

• 3:20pm - 3:25pm

  Closing Remarks
  

• 11:00am - 11:10am

  Opening Remarks
  Robert J. Mayer MD – Course Director

Sarcoma

Moderator: Dr. Mayer

• 11:10am - 11:40am

  Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma
  George D. Demetri MD

Gastrointestinal Cancers

Moderator: Dr. Mayer

• 11:40am - 12:25pm

  Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers
  Peter C. Enzinger MD

• 12:25pm - 1:05pm

  Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy
  Matthew B. Yurgelun MD

• 1:05pm - 1:35pm

  Session Break
  

• 1:35pm - 2:05pm

  Reducing Risk: Current Clinical Evidence on Lifestyle Management and Chemopreventative Agents in Gastrointestinal Cancer
  Charles S. Fuchs MD, MPH

• 2:05pm - 2:50pm

  Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment
  Robert J. Mayer MD

• 2:50pm - 3:20pm

  Panel Discussion
  

  All Faculty

• 3:20pm - 3:25pm

  Closing Remarks
  

• 11:00am - 11:10am

  Opening Remarks
  Robert J. Mayer MD – Course Director

Head, Neck and Lung Cancers

Moderator: Dr. Johnson

• 11:10am - 11:50am

  Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers
  Robert I. Haddad MD

• 11:50am - 12:45pm

  NSCLC and SCLC: Molecular Testing and Emerging Treatment Options
  Bruce E. Johnson MD

• 12:45pm - 1:15pm

  Session Break
  

Melanoma Cancer

Track Leader: Dr. Johnson

• 1:15pm - 1:50pm

  Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma
  F. Stephen Hodi MD

• 1:50pm - 2:20pm

  Panel Discussion
  

  All Faculty

• 2:25pm - 2:30pm

  Closing Remarks
  

• 11:00am - 11:10am

  Opening Remarks
  Robert J. Mayer MD – Course Director

Moderator: Dr. Johnson

• 11:10am - 11:30am

  COVID and Cancer Treatment
  Amy C. Bessnow MD, MPH

Genitourinary Cancers

Moderator: Dr. Johnson

• 11:30am - 12:20pm

  Prostate Cancer: An Evolving Treatment Landscape
  William K. Oh MD

• 12:20pm - 12:50pm

  Session Break
  

• 12:50pm - 1:25pm

  Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice
  Robert Dreicer MD

• 1:25pm - 1:55pm

  Panel Discussion
  

  All Faculty

• 1:55pm - 2:00pm

  Closing Remarks